"Sputnik V" vaccine: WHO and international scientists call for caution

Samples of a coronavirus vaccine developed by the Gamaleya Research Institute in Epidemiology and Microbiology, in Moscow, Russia, August 6, 2020. The Russian Direct Investment Fund (RDIF) / Handout via REUTERS

Text by: RFI Follow

2 min

Russian President Vladimir Putin said on Tuesday morning that Russia has developed the first vaccine against the coronavirus. Called "Sputnik V", it would have passed "all the necessary checks" according to Vladimir Poutine and would function "fairly efficiently". The World Health Organization and international scientists call for caution.

Publicity

Read more

For a vaccine to be approved, that is to say certified compliant by the World Health Organization (WHO), it goes through “  rigorous procedures  ” according to the international institution.

To be approved by the WHO, “Sputnik V” will therefore have to go through three phases of evaluation which test the safety and efficacy of the product with clinical trials.

See also: Coronavirus: Russia claims to have developed the "first" vaccine

From last week, the international body showed its doubts about the rigor of the procedures used by Russia.

The vaccine was then “  almost ready  ” depending on the country without however communicating the results of its study on the effectiveness of the product to the WHO. And since then, the laboratory in charge of research has still not published anything.

Without possession of official data, and after less than two months of clinical trials on humans, several British scientists are worried about Russian claims. In Berlin, the German Ministry of Health also spoke on Tuesday evening. He doesn't trust this vaccine either.

“One to two years” of study

It is difficult to ensure at this time that the vaccine which should be put into circulation on January 1, 2021 can actually be distributed, as explained by Professor Frédéric Adnet, professor of emergency medicine at the University of the Sorbonne and head of the emergency department of the Avicenne hospital in Bobigny.

You understand when you vaccinate 30,000 people, you have to wait until a certain number of patients, those who received the placebo, can develop the disease, and those who have had the vaccine never develop the disease. Studies like that in normal times, it can last one to two years.

Prof. Frédéric Adnet, professor of medicine and chief emergency doctor

Nicolas rocca

Our selection on the coronavirus

Listen to our Coronavirus Info column 

Our  explanations  :
→  What we know about the mode of contagion
→  Disparities and inequalities in the face of the coronavirus
→  Triple therapy, Discovery… update on research
→  Remdesivir, antibodies and immunity
→  The vaccine race is in full swing
→  How to make a mask and use it well

Our series  :
→ “  The response, country by country  ”
→ “  Nurses  ' words

After Covid-19, towards a new world?

See also the records of RFI Knowledge on Covid-19
→  Birth of a pandemic
→  Daily proof
→  The history of epidemics
→  Science facing Covid-19
→  The geopolitical consequences

Newsletter Receive all international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application

google-play-badge_FR

  • Russia
  • Coronavirus
  • Health and medicine
  • Research
  • WHO

On the same subject

Coronavirus: Russia claims to have developed "first" vaccine

Africa report

The bat at the heart of coronavirus research in Zimbabwe

Covid-19: London accuses Moscow of trying to steal vaccine research